Arcellx

Yahoo Finance • 5 days ago

Gilead to acquire Tubulis GmbH for $5B

[Gilead Sciences, Inc. headquarters in Silicon Valley] Sundry Photography Gilead (GILD [https://seekingalpha.com/symbol/GILD]) said on Tuesday that it would acquire Germany-based biotechnology firm Tubulis GmbH for $5B to build on its onc... Full story

Yahoo Finance • 5 days ago

Gilead to acquire Tubulis GmbH for up to $5 billion

April 7 (Reuters) - Gilead said on Tuesday it would acquire private Germany-based Tubulis GmbH for ‌up to $5 billion, as the U.S. drugmaker ‌looks to boost its pipeline with a lucrative class of ​experimental cancer drugs referred to as "g... Full story

Yahoo Finance • 11 days ago

Gilead Extends Tender Offer to Acquire Arcellx

FOSTER CITY, Calif., April 01, 2026--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today extended the expiration of the tender offer to purchase all outstanding shares of common stock of Arcellx. The offer remains at a purchase pri... Full story

Yahoo Finance • 20 days ago

Gilead to buy Ouro Medicines for up to $2.2 billion

Investing.com -- Gilead Sciences Inc. announced Monday it has entered into a definitive agreement to acquire Ouro Medicines, a privately held biotechnology company focused on developing T cell engager therapies for autoimmune diseases. Th... Full story

Yahoo Finance • 20 days ago

Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Initiating Coverage with a Valuation of $12.00/Share from Zacks Small-Cap Research

EMERYVILLE, Calif., March 23, 2026--(BUSINESS WIRE)--Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) ("Estrella" or the "Company"), a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to... Full story

Yahoo Finance • 21 days ago

Olema Stock Up 242%, but Does a $122 Million Position Suggest More Upside Potential?

On February 17, 2026, Paradigm Biocapital Advisors LP disclosed a buy of 750,000 shares of Olema Pharmaceuticals(NASDAQ:OLMA) in Q4 2025, an estimated $13.35 million trade based on quarter-end pricing. What happened According to a Securi... Full story

Yahoo Finance • 26 days ago

Gilead Sciences at Barclays: CFO touts YEZTUGO launch, Arcellx deal and “long cycle” growth

Gilead Sciences logo 3 Blue-Chip Stocks Built for a Rotating Market Gilead Sciences (NASDAQ:GILD) Chief Financial Officer Andrew Dickinson told investors at the Barclays conference that the company is entering what he described as “the b... Full story

Yahoo Finance • 30 days ago

How Renewed Wall Street Optimism Around HIV, Oncology And IP Runway At Gilead Sciences (GILD) Has Changed Its Investment Story

In recent days, Jefferies and other Wall Street firms initiated and reiterated positive coverage on Gilead Sciences, highlighting its strong HIV franchise, deep oncology pipeline, and an intellectual-property runway that extends to 2036. A... Full story

Yahoo Finance • last month

Halper Sadeh LLC is Investigating Whether ACLX, VRE, EHAB are Obtaining Fair Deals for their Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm... Full story

Yahoo Finance • last month

Arcellx President Sells $10M Worth of Shares After Acquisition Announcement

Rami Elghandour, President of Arcellx(NASDAQ:ACLX), sold 89,916 shares for approximately $10.24 million on Feb. 27, 2026, according to a SEC Form 4 filing. Transaction summary Metric Value Shares sold (direct) 89,916 Transaction value $1... Full story

Yahoo Finance • last month

Notable healthcare headlines for the week: Viatris, Novo Nordisk, and Gilead Sciences in focus

Wall Street’s major market averages finished lower on Friday after the January wholesale inflation report came in hotter than expected. The blue-chip Dow was last lower by 1%, while the benchmark S&P 500 was -0.4%. At the same time, the t... Full story

Yahoo Finance • 2 months ago

Halper Sadeh LLC is Investigating Whether ACLX, EHAB, VRE are Obtaining Fair Deals for their Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm... Full story

Yahoo Finance • 2 months ago

$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—KW, MASI, ACLX, and VRE

NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in th... Full story

Yahoo Finance • 2 months ago

Qualcomm, Booking Holdings upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Loop Capital upgraded Qualcomm (QCOM)... Full story

Yahoo Finance • 2 months ago

Stocks Finish Sharply Lower on Trade Uncertainty and AI-Disruption Fears

The S&P 500 Index ($SPX) (SPY) on Monday closed down -1.04%, the Dow Jones Industrial Average ($DOWI) (DIA) closed down -1.66%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -1.21%.  March E-mini S&P futures (ESH26) fell -1.02%, and M... Full story

Yahoo Finance • 2 months ago

Stock market today: Dow drops 800 points as S&P 500, Nasdaq slide on Trump tariff fears, AI 'scare trade'

US stocks retreated on Monday as investors grappled with the fallout from the Supreme Court's rebuff of President Trump's most sweeping tariffs, while AI disruption fears gripped markets once again. The Dow Jones Industrial Average (^DJI)... Full story

Yahoo Finance • 2 months ago

Stocks Retreat on US Trade Uncertainty and Fresh AI Worries

The S&P 500 Index ($SPX) (SPY) today is down -1.20%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -1.58%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -1.47%.  March E-mini S&P futures (ESH26) are down -1.23%, and March E-mini... Full story

Yahoo Finance • 2 months ago

Stocks Slip on US Trade Uncertainty

The S&P 500 Index ($SPX) (SPY) today is down -0.22%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -0.24%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.66%.  March E-mini S&P futures (ESH26) are down -0.25%, and March E-mini... Full story

Yahoo Finance • 2 months ago

Stocks making the biggest moves midday: KKR, Blackstone, CrowdStrike, International Paper & more

Check out the companies making the biggest moves midday: Financials – The financials sector of the S & P 500 slid more than 3% in midday trading, the worst performer in the broad market. Alternative asset managers KKR and Blackstone slid r... Full story

Yahoo Finance • 2 months ago

$80 Million Arcellx Sale Follows Steep Stock Drop as Rival Drug Emerges

Perceptive Advisors disclosed a sale of 1,002,282 Arcellx(NASDAQ:ACLX) shares in a February 17, 2026, SEC filing, with the estimated transaction value at $79.96 million based on quarterly average pricing. What happened According to a SEC... Full story